<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04853641</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY20070432</org_study_id>
    <nct_id>NCT04853641</nct_id>
  </id_info>
  <brief_title>Impact of Age and BMI on Liver Transplant Outcomes</brief_title>
  <official_title>The Impact of Advanced Age and High BMI on Short-term Outcomes in Live-donor Liver Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospectively enrolled retrospective chart review and Liver Transplant database review to&#xD;
      determine the modifiable and nonmodifiable risk factors specifically relating to Living Donor&#xD;
      Liver Transplants. To observe the impact of age and BMI on graft outcomes and whether they&#xD;
      impact the intraoperative management, post-operative length of stay, and complications.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There has been a great deal of research into the characteristics of the donor for organ&#xD;
      transplant, with older donors and those with more comorbidities having worse function once&#xD;
      the organ is implanted. There has not been a great deal of research in the United States&#xD;
      about the recipient's characteristic including age and BMI and the effects on donor organ&#xD;
      function. With increasingly expanded criteria for organ recipients especially in the field of&#xD;
      living donor organs the investigators plan to show the impact of older age and increased BMI&#xD;
      on newly transplanted organs.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Graft Function 30 day</measure>
    <time_frame>30 day</time_frame>
    <description>How well does the organ function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>1 year</time_frame>
    <description>Mortality at 1 year</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Graft Survival 1 year</measure>
    <time_frame>1 year</time_frame>
    <description>Survival of Organ at 1 year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative Complications</measure>
    <time_frame>30 day</time_frame>
    <description>Any complications in the perioperative period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay- Total and ICU</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>How long after surgery before patient is discharged from ICU and from Hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Intubation/Ventilation</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Time from Surgery End to Extubation or no longer requiring ventilatory support</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Complications</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Complications in the postoperative period- Renal, Infectious Disease, Pulmonary, Cardiac, Transplant related, Reintubation, Reoperation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Transfusion</measure>
    <time_frame>Up to 2 days</time_frame>
    <description>Amount of blood transfusion required intraoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasoactive Medication</measure>
    <time_frame>Up to 2 days</time_frame>
    <description>Amount and Type of Vasoactive Medication used at procedure end</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Liver Transplant; Complications</condition>
  <condition>Perioperative/Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Living Donor Liver Transplant Recipient</arm_group_label>
    <description>Patients who have received a living donor liver transplant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deceased Donor Liver Transplant Recipient</arm_group_label>
    <description>Patients who have received either a Deceased by Circulatory Death or Deceased by Brain Death Liver Transplant</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cadaveric</intervention_name>
    <description>Cadaveric Organ Transplant</description>
    <arm_group_label>Deceased Donor Liver Transplant Recipient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Living Donor</intervention_name>
    <description>Living Donor Organ Transplant</description>
    <arm_group_label>Living Donor Liver Transplant Recipient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with end-stage liver disease, cirrhosis, or cancer requiring a liver transplant.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients who received a liver transplant at UPMC- Montefiore Hospital Age&gt; 18&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Excludes Children (&lt;18 years old) as they do not receive their operation under the&#xD;
             same protocols Lost to follow-up prior to 1 year Participation in alternate research&#xD;
             protocol that significantly altered the care they received in the perioperative period&#xD;
             that may make their inclusion skew results.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UPMC Montefiore</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2021</study_first_posted>
  <last_update_submitted>April 16, 2021</last_update_submitted>
  <last_update_submitted_qc>April 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Michael Trostler</investigator_full_name>
    <investigator_title>Liver Transplant Anesthesia Fellow</investigator_title>
  </responsible_party>
  <keyword>Age Related Outcomes</keyword>
  <keyword>BMI related outcomes</keyword>
  <keyword>Liver Transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No current plans</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

